Genome-wide association study in obsessive-compulsive disorder: results from the OCGAS - PubMed (original) (raw)
doi: 10.1038/mp.2014.43. Epub 2014 May 13.
J F Samuels 2, Y Wang 2, B D Greenberg 3, A J Fyer 4, J T McCracken 5, D A Geller 6, D L Murphy 7, J A Knowles 8, M A Grados 2, M A Riddle 2, S A Rasmussen 3, N C McLaughlin 3, E L Nurmi 5, K D Askland 3, H-D Qin 9, B A Cullen 2, J Piacentini 5, D L Pauls 6, O J Bienvenu 2, S E Stewart 10, K-Y Liang 11, F S Goes 2, B Maher 11, A E Pulver 2, Y Y Shugart 9, D Valle 12, C Lange 13, G Nestadt 2
Affiliations
- PMID: 24821223
- PMCID: PMC4231023
- DOI: 10.1038/mp.2014.43
Genome-wide association study in obsessive-compulsive disorder: results from the OCGAS
M Mattheisen et al. Mol Psychiatry. 2015 Mar.
Abstract
Obsessive-compulsive disorder (OCD) is a psychiatric condition characterized by intrusive thoughts and urges and repetitive, intentional behaviors that cause significant distress and impair functioning. The OCD Collaborative Genetics Association Study (OCGAS) is comprised of comprehensively assessed OCD patients with an early age of OCD onset. After application of a stringent quality control protocol, a total of 1065 families (containing 1406 patients with OCD), combined with population-based samples (resulting in a total sample of 5061 individuals), were studied. An integrative analyses pipeline was utilized, involving association testing at single-nucleotide polymorphism (SNP) and gene levels (via a hybrid approach that allowed for combined analyses of the family- and population-based data). The smallest P-value was observed for a marker on chromosome 9 (near PTPRD, P=4.13 × 10(-)(7)). Pre-synaptic PTPRD promotes the differentiation of glutamatergic synapses and interacts with SLITRK3. Together, both proteins selectively regulate the development of inhibitory GABAergic synapses. Although no SNPs were identified as associated with OCD at genome-wide significance level, follow-up analyses of genome-wide association study (GWAS) signals from a previously published OCD study identified significant enrichment (P=0.0176). Secondary analyses of high-confidence interaction partners of DLGAP1 and GRIK2 (both showing evidence for association in our follow-up and the original GWAS study) revealed a trend of association (P=0.075) for a set of genes such as NEUROD6, SV2A, GRIA4, SLC1A2 and PTPRD. Analyses at the gene level revealed association of IQCK and C16orf88 (both P<1 × 10(-)(6), experiment-wide significant), as well as OFCC1 (P=6.29 × 10(-)(5)). The suggestive findings in this study await replication in larger samples.
Conflict of interest statement
Conflict of interest
The authors declare no conflicts of interest.
Figures
Figure 1. Manhattan plot for OCGAS GWAS
Shown are the result for the hybrid analysis of the within and between family component of the OCGAS GWAS. A thin blue line indicates level of suggestive evidence for association (1 × 10−5) and a thin red line indicates genome-wide significance (5 × 10−8).
Figure 2. Regional association plots for top regions in OCGAS GWAS
The most associated marker in the region (see table 2 and S2, purple dot) is centered in a genomic window of 5 Mb (hg19). P-values for the OCGAS GWAS are given. The linkage disequilibrium (LD) strength (r2; data from the 1000 genomes project European samples) between the sentinel single nucleotide polymorphism and its flanking markers is demonstrated by the coloring of the dots for the neighboring markers (ranging from red = high to blue = low). The recombination rate (cM/Mb; second y axis) is plotted in blue. Plots are given for the a) chromosome 9 region harboring PTPRD (clump 1 in table 2), b) the chromosome 5 region (clump 2 in table 2), and c) the chromosome 16 region harboring the two genes that were identified in the gene-based analysis, IQCK and C16orf88.
Figure 2. Regional association plots for top regions in OCGAS GWAS
The most associated marker in the region (see table 2 and S2, purple dot) is centered in a genomic window of 5 Mb (hg19). P-values for the OCGAS GWAS are given. The linkage disequilibrium (LD) strength (r2; data from the 1000 genomes project European samples) between the sentinel single nucleotide polymorphism and its flanking markers is demonstrated by the coloring of the dots for the neighboring markers (ranging from red = high to blue = low). The recombination rate (cM/Mb; second y axis) is plotted in blue. Plots are given for the a) chromosome 9 region harboring PTPRD (clump 1 in table 2), b) the chromosome 5 region (clump 2 in table 2), and c) the chromosome 16 region harboring the two genes that were identified in the gene-based analysis, IQCK and C16orf88.
Figure 2. Regional association plots for top regions in OCGAS GWAS
The most associated marker in the region (see table 2 and S2, purple dot) is centered in a genomic window of 5 Mb (hg19). P-values for the OCGAS GWAS are given. The linkage disequilibrium (LD) strength (r2; data from the 1000 genomes project European samples) between the sentinel single nucleotide polymorphism and its flanking markers is demonstrated by the coloring of the dots for the neighboring markers (ranging from red = high to blue = low). The recombination rate (cM/Mb; second y axis) is plotted in blue. Plots are given for the a) chromosome 9 region harboring PTPRD (clump 1 in table 2), b) the chromosome 5 region (clump 2 in table 2), and c) the chromosome 16 region harboring the two genes that were identified in the gene-based analysis, IQCK and C16orf88.
Similar articles
- Revealing the complex genetic architecture of obsessive-compulsive disorder using meta-analysis.
International Obsessive Compulsive Disorder Foundation Genetics Collaborative (IOCDF-GC) and OCD Collaborative Genetics Association Studies (OCGAS). International Obsessive Compulsive Disorder Foundation Genetics Collaborative (IOCDF-GC) and OCD Collaborative Genetics Association Studies (OCGAS). Mol Psychiatry. 2018 May;23(5):1181-1188. doi: 10.1038/mp.2017.154. Epub 2017 Aug 1. Mol Psychiatry. 2018. PMID: 28761083 Free PMC article. - Genetic meta-analysis of obsessive-compulsive disorder and self-report compulsive symptoms.
Smit DJA, Cath D, Zilhão NR, Ip HF, Denys D, den Braber A, de Geus EJC, Verweij KJH, Hottenga JJ, Boomsma DI. Smit DJA, et al. Am J Med Genet B Neuropsychiatr Genet. 2020 Jun;183(4):208-216. doi: 10.1002/ajmg.b.32777. Epub 2019 Dec 31. Am J Med Genet B Neuropsychiatr Genet. 2020. PMID: 31891238 Free PMC article. - Genome-wide linkage analysis of obsessive-compulsive disorder implicates chromosome 1p36.
Mathews CA, Badner JA, Andresen JM, Sheppard B, Himle JA, Grant JE, Williams KA, Chavira DA, Azzam A, Schwartz M, Reus VI, Kim SW, Cook EH, Hanna GL. Mathews CA, et al. Biol Psychiatry. 2012 Oct 15;72(8):629-36. doi: 10.1016/j.biopsych.2012.03.037. Epub 2012 May 25. Biol Psychiatry. 2012. PMID: 22633946 Free PMC article. - The need for inclusion of sex and age of onset variables in genetic association studies of obsessive-compulsive disorder: Overview.
Mattina GF, Steiner M. Mattina GF, et al. Prog Neuropsychopharmacol Biol Psychiatry. 2016 Jun 3;67:107-16. doi: 10.1016/j.pnpbp.2016.01.012. Epub 2016 Jan 28. Prog Neuropsychopharmacol Biol Psychiatry. 2016. PMID: 26827635 Review. - Genetics of early-onset obsessive-compulsive disorder.
Walitza S, Wendland JR, Gruenblatt E, Warnke A, Sontag TA, Tucha O, Lange KW. Walitza S, et al. Eur Child Adolesc Psychiatry. 2010 Mar;19(3):227-35. doi: 10.1007/s00787-010-0087-7. Epub 2010 Mar 6. Eur Child Adolesc Psychiatry. 2010. PMID: 20213231 Review.
Cited by
- Specialty knowledge and competency standards for pharmacotherapy for adult obsessive-compulsive disorder.
Pittenger C, Brennan BP, Koran L, Mathews CA, Nestadt G, Pato M, Phillips KA, Rodriguez CI, Simpson HB, Skapinakis P, Stein DJ, Storch EA. Pittenger C, et al. Psychiatry Res. 2021 Jun;300:113853. doi: 10.1016/j.psychres.2021.113853. Epub 2021 Mar 4. Psychiatry Res. 2021. PMID: 33975093 Free PMC article. - General personality dimensions, impairment and treatment response in obsessive-compulsive disorder.
Samuels J, Bienvenu OJ, Krasnow J, Wang Y, Grados MA, Cullen B, Goes FS, Maher B, Greenberg BD, Mclaughlin NC, Rasmussen SA, Fyer AJ, Knowles JA, Mccracken JT, Piacentini J, Geller D, Stewart SE, Murphy DL, Shugart YY, Riddle MA, Nestadt G. Samuels J, et al. Personal Ment Health. 2020 May;14(2):186-198. doi: 10.1002/pmh.1472. Epub 2019 Dec 20. Personal Ment Health. 2020. PMID: 31859455 Free PMC article. - De Novo Damaging DNA Coding Mutations Are Associated With Obsessive-Compulsive Disorder and Overlap With Tourette's Disorder and Autism.
Cappi C, Oliphant ME, Péter Z, Zai G, Conceição do Rosário M, Sullivan CAW, Gupta AR, Hoffman EJ, Virdee M, Olfson E, Abdallah SB, Willsey AJ, Shavitt RG, Miguel EC, Kennedy JL, Richter MA, Fernandez TV. Cappi C, et al. Biol Psychiatry. 2020 Jun 15;87(12):1035-1044. doi: 10.1016/j.biopsych.2019.09.029. Epub 2019 Oct 16. Biol Psychiatry. 2020. PMID: 31771860 Free PMC article. - Genetics of obsessive-compulsive disorder.
Purty A, Nestadt G, Samuels JF, Viswanath B. Purty A, et al. Indian J Psychiatry. 2019 Jan;61(Suppl 1):S37-S42. doi: 10.4103/psychiatry.IndianJPsychiatry_518_18. Indian J Psychiatry. 2019. PMID: 30745675 Free PMC article. Review. - In search of environmental risk factors for obsessive-compulsive disorder: study protocol for the OCDTWIN project.
Mataix-Cols D, Fernández de la Cruz L, De Schipper E, Kuja-Halkola R, Bulik CM, Crowley JJ, Neufeld J, Rück C, Tammimies K, Lichtenstein P, Bölte S, Beucke JC. Mataix-Cols D, et al. BMC Psychiatry. 2023 Jun 16;23(1):442. doi: 10.1186/s12888-023-04897-4. BMC Psychiatry. 2023. PMID: 37328750 Free PMC article.
References
- Weissman MM, Bland RC, Canino GJ, Greenwald S, Hwu HG, Lee CK, et al. The cross national epidemiology of obsessive compulsive disorder. The Cross National Collaborative Group. The Journal of clinical psychiatry. 1994;55 (Suppl):5–10. - PubMed
- Karno M, Golding J. Obsessive compulsive disorder. In: Robins L, Regier D, editors. Psychiatric Disorders in America: The epidemiologic catchment area study. Free Press; New York: 1991. pp. 204–219.
- Murray C, Lopez A. The global burden of disease: a comprehensive assessment of mortality and disability from diseases, injuries and risk factors in 1990 and projected to 2020. Vol. 1. Harvard University Press; Cambridge: 1996.
- Nestadt G, Samuels J, Riddle M, Bienvenu OJ, 3rd, Liang KY, LaBuda M, et al. A family study of obsessive-compulsive disorder. Archives of general psychiatry. 2000;57(4):358–363. - PubMed
- Riddle MA, Scahill L, King R, Hardin MT, Towbin KE, Ort SI, et al. Obsessive compulsive disorder in children and adolescents: phenomenology and family history. Journal of the American Academy of Child and Adolescent Psychiatry. 1990;29(5):766–772. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- R01 MH079487/MH/NIMH NIH HHS/United States
- R01 MH071507/MH/NIMH NIH HHS/United States
- MH079487/MH/NIMH NIH HHS/United States
- R01 MH079489/MH/NIMH NIH HHS/United States
- R01 MH079494/MH/NIMH NIH HHS/United States
- MH071507/MH/NIMH NIH HHS/United States
- ImNIH/Intramural NIH HHS/United States
- MH079488/MH/NIMH NIH HHS/United States
- K23 MH094613/MH/NIMH NIH HHS/United States
- MH079489/MH/NIMH NIH HHS/United States
- MH079494/MH/NIMH NIH HHS/United States
- R01 MH079488/MH/NIMH NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical